India’s Hetero pulls heart drug from U.S. amid cancer risk probes
IN -

A unit of India’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S. regulator's website said, amid a wider probe into cancer risks associated with the drug.

In related news